NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) Stock Fundamental Analysis

TSX:NWH-DB-H • CA667495AJ41

101 CAD
+0.02 (+0.02%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NWH-DB-H. NWH-DB-H was compared to 36 industry peers in the Diversified REITs industry. There are concerns on the financial health of NWH-DB-H while its profitability can be described as average. NWH-DB-H is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year NWH-DB-H was profitable.
  • In the past year NWH-DB-H had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NWH-DB-H reported negative net income in multiple years.
  • NWH-DB-H had a positive operating cash flow in each of the past 5 years.
NWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With a Return On Assets value of 0.82%, NWH-DB-H perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • The Return On Equity of NWH-DB-H (3.06%) is comparable to the rest of the industry.
  • With a Return On Invested Capital value of 3.41%, NWH-DB-H is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • NWH-DB-H had an Average Return On Invested Capital over the past 3 years of 3.40%. This is below the industry average of 5.59%.
  • The last Return On Invested Capital (3.41%) for NWH-DB-H is above the 3 year average (3.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROIC 3.41%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.4%
ROIC(5y)3.4%
NWH-DB-H.CA Yearly ROA, ROE, ROICNWH-DB-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • NWH-DB-H has a Profit Margin of 11.90%. This is comparable to the rest of the industry: NWH-DB-H outperforms 55.56% of its industry peers.
  • With a decent Operating Margin value of 61.05%, NWH-DB-H is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • In the last couple of years the Operating Margin of NWH-DB-H has declined.
  • Looking at the Gross Margin, with a value of 74.32%, NWH-DB-H belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • NWH-DB-H's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
OM growth 3Y-1.41%
OM growth 5Y-1.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
NWH-DB-H.CA Yearly Profit, Operating, Gross MarginsNWH-DB-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NWH-DB-H is destroying value.
  • NWH-DB-H has more shares outstanding than it did 1 year ago.
  • NWH-DB-H has more shares outstanding than it did 5 years ago.
  • NWH-DB-H has a better debt/assets ratio than last year.
NWH-DB-H.CA Yearly Shares OutstandingNWH-DB-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NWH-DB-H.CA Yearly Total Debt VS Total AssetsNWH-DB-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • NWH-DB-H has an Altman-Z score of 3.37. This indicates that NWH-DB-H is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.37, NWH-DB-H belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
  • NWH-DB-H has a debt to FCF ratio of 24.51. This is a negative value and a sign of low solvency as NWH-DB-H would need 24.51 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 24.51, NWH-DB-H is doing worse than 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 1.47 is on the high side and indicates that NWH-DB-H has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.47, NWH-DB-H is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Altman-Z 3.37
ROIC/WACC0.45
WACC7.54%
NWH-DB-H.CA Yearly LT Debt VS Equity VS FCFNWH-DB-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.16 indicates that NWH-DB-H may have some problems paying its short term obligations.
  • With a Current ratio value of 0.16, NWH-DB-H is not doing good in the industry: 63.89% of the companies in the same industry are doing better.
  • NWH-DB-H has a Quick Ratio of 0.16. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NWH-DB-H's Quick ratio of 0.16 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NWH-DB-H.CA Yearly Current Assets VS Current LiabilitesNWH-DB-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 109.98% over the past year.
  • NWH-DB-H shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.34%.
  • NWH-DB-H shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.78% yearly.
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-H.CA Yearly Revenue VS EstimatesNWH-DB-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-H.CA Yearly EPS VS EstimatesNWH-DB-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 505.00 indicates a quite expensive valuation of NWH-DB-H.
  • NWH-DB-H's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of NWH-DB-H to the average of the S&P500 Index (26.99), we can say NWH-DB-H is valued expensively.
Industry RankSector Rank
PE 505
Fwd PE N/A
NWH-DB-H.CA Price Earnings VS Forward Price EarningsNWH-DB-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as NWH-DB-H.
  • NWH-DB-H's Price/Free Cash Flow ratio is rather expensive when compared to the industry. NWH-DB-H is more expensive than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 212.65
EV/EBITDA 109.18
NWH-DB-H.CA Per share dataNWH-DB-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 10.04%, NWH-DB-H is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 7.01, NWH-DB-H pays a better dividend. On top of this NWH-DB-H pays more dividend than 91.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, NWH-DB-H pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

  • The dividend of NWH-DB-H decreases each year by -13.72%.
  • NWH-DB-H is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)-13.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 154.63% of the earnings are spent on dividend by NWH-DB-H. This is not a sustainable payout ratio.
DP154.63%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-H.CA Yearly Income VS Free CF VS DividendNWH-DB-H.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
NWH-DB-H.CA Dividend Payout.NWH-DB-H.CA Dividend Payout, showing the Payout Ratio.NWH-DB-H.CA Dividend Payout.PayoutRetained Earnings

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-H (2/20/2026, 7:00:00 PM)

101

+0.02 (+0.02%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-11
Earnings (Next)02-24
Inst Owners10.73%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap25.25B
Revenue(TTM)417.64M
Net Income(TTM)49.70M
Analysts70
Price Target107.01 (5.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.32
Dividend Growth(5Y)-13.72%
DP154.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.34%
PT rev (3m)-5.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 505
Fwd PE N/A
P/S 60.46
P/FCF 212.65
P/OCF 209.51
P/B 15.56
P/tB 16.41
EV/EBITDA 109.18
EPS(TTM)0.2
EY0.2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.47
FCFY0.47%
OCF(TTM)0.48
OCFY0.48%
SpS1.67
BVpS6.49
TBVpS6.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.41
Profitability
Industry RankSector Rank
ROA 0.82%
ROE 3.06%
ROCE 4.73%
ROIC 3.41%
ROICexc 3.46%
ROICexgc 3.52%
OM 61.05%
PM (TTM) 11.9%
GM 74.32%
FCFM 28.43%
ROA(3y)-2.92%
ROA(5y)0.56%
ROE(3y)-11.33%
ROE(5y)0.68%
ROIC(3y)3.4%
ROIC(5y)3.4%
ROICexc(3y)3.44%
ROICexc(5y)3.45%
ROICexgc(3y)3.5%
ROICexgc(5y)3.52%
ROCE(3y)4.73%
ROCE(5y)4.72%
ROICexgc growth 3Y6.32%
ROICexgc growth 5Y0.97%
ROICexc growth 3Y6.47%
ROICexc growth 5Y1.1%
OM growth 3Y-1.41%
OM growth 5Y-1.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.75%
GM growth 5Y-0.16%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF 24.51
Debt/EBITDA 9.29
Cap/Depr 80.78%
Cap/Sales 0.43%
Interest Coverage 1.76
Cash Conversion 46.86%
Profit Quality 238.9%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.37
F-Score5
WACC7.54%
ROIC/WACC0.45
Cap/Depr(3y)24.87%
Cap/Depr(5y)24.57%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.34%
Revenue growth 3Y7.27%
Revenue growth 5Y4.78%
Sales Q2Q%-2.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35%
EBIT growth 3Y5.76%
EBIT growth 5Y2.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.08%
FCF growth 3Y-11.68%
FCF growth 5Y-7.73%
OCF growth 1Y-11.91%
OCF growth 3Y-11.5%
OCF growth 5Y-7.59%

NORTHWEST HEALTHCARE PRO / NWH-DB-H.CA FAQ

What is the ChartMill fundamental rating of NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NWH-DB-H.CA.


Can you provide the valuation status for NORTHWEST HEALTHCARE PRO?

ChartMill assigns a valuation rating of 1 / 10 to NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA). This can be considered as Overvalued.


How profitable is NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) stock?

NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) has a profitability rating of 4 / 10.


Is the dividend of NORTHWEST HEALTHCARE PRO sustainable?

The dividend rating of NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) is 4 / 10 and the dividend payout ratio is 154.63%.